Published in Exp Neurol on June 21, 2013
Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis. PLoS One (2014) 0.96
Inherited disorders of the neuromuscular junction: an update. J Neurol (2014) 0.83
Congenital Myasthenic Syndromes with Predominant Limb Girdle Weakness. J Neuromuscul Dis (2015) 0.75
Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet (2001) 5.09
A cellular mechanism of reward-related learning. Nature (2001) 4.09
In polarized MDCK cells basolateral vesicles arise from clathrin-gamma-adaptin-coated domains on endosomal tubules. J Cell Biol (1998) 2.95
Red wine and antioxidant activity in serum. Lancet (1994) 2.54
Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol (1997) 2.17
Inflammation, depressive symptomtology, and coronary artery disease. Psychosom Med (2001) 2.03
Properties of the human muscle nicotinic receptor, and of the slow-channel myasthenic syndrome mutant epsilonL221F, inferred from maximum likelihood fits. J Physiol (2003) 1.99
Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'. Brain (2006) 1.95
Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet (1995) 1.94
Classification and characteristics of coagulase-negative, methicillin-resistant staphylococci. J Clin Microbiol (1980) 1.86
The vitamin D content of fortified milk and infant formula. N Engl J Med (1992) 1.83
Comparative surface-to-hand and fingertip-to-mouth transfer efficiency of gram-positive bacteria, gram-negative bacteria, and phage. J Appl Microbiol (2002) 1.77
Dopamine D-1/D-5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro. J Neurophysiol (2001) 1.66
Long-term care hospitals under Medicare: facility-level characteristics. Health Care Financ Rev (2001) 1.55
Arteriohepatic dysplasia and cardiovascular malformations. Am Heart J (1994) 1.54
Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness. J Clin Psychopharmacol (2000) 1.51
Postnatal development of alveoli. Regulation and evidence for a critical period in rats. J Clin Invest (1985) 1.51
Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann Neurol (1997) 1.50
Contamination of laryngoscopes. Anaesthesia (1999) 1.49
Sorting mechanisms regulating membrane protein traffic in the apical transcytotic pathway of polarized MDCK cells. J Cell Biol (1998) 1.39
Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem Biophys Res Commun (1996) 1.38
Reduced transfer of tetanus antibodies with placental malaria. Lancet (1994) 1.35
Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome. Hum Mol Genet (1997) 1.33
A cross-national study of differences in the identities of nursing in England and Australia and how this has affected nurses' capacity to respond to hospital reform. Nurs Inq (2000) 1.28
Congenital myasthenic syndromes in childhood: diagnostic and management challenges. J Neuroimmunol (2008) 1.22
Small fiber neuropathy: a common and important clinical disorder. J Neurol Sci (2004) 1.19
Dopamine and synaptic plasticity in the neostriatum. J Anat (2000) 1.18
Different isozymes of mouse 11 beta-hydroxylase produce mineralocorticoids and glucocorticoids. Mol Endocrinol (1991) 1.15
Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis. Neurology (2005) 1.14
ECG abnormalities in co-proxamol (paracetamol/dextropropoxyphene) poisoning. Clin Toxicol (Phila) (2005) 1.14
Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes. Neurology (2003) 1.13
Substantia nigra dopamine regulates synaptic plasticity and membrane potential fluctuations in the rat neostriatum, in vivo. Neuroscience (2000) 1.12
Continuing improvements in valvular bioprostheses. J Thorac Cardiovasc Surg (1982) 1.09
A 15 amino acid fragment of influenza nucleoprotein synthesized in the cytoplasm is presented to class I-restricted cytotoxic T lymphocytes. J Exp Med (1989) 1.09
Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7. Neurology (2010) 1.08
Distinct phenotypes of congenital acetylcholine receptor deficiency. Neuromuscul Disord (2004) 1.08
Goodpasture antigen-binding protein, the kinase that phosphorylates the goodpasture antigen, is an alternatively spliced variant implicated in autoimmune pathogenesis. J Biol Chem (2000) 1.07
Exercise metabolism in healthy volunteers taking celiprolol, atenolol, and placebo. Br J Sports Med (1997) 1.06
Two outbreaks of Legionnaires' disease in Bolton Health District. Epidemiol Infect (1990) 1.05
When "enough" is not enough: new perspectives on optimal methadone maintenance dose. Mt Sinai J Med (2000) 1.05
Hydrogen gas reduced acute hyperglycemia-enhanced hemorrhagic transformation in a focal ischemia rat model. Neuroscience (2010) 1.04
Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes. Neurology (2002) 1.04
Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology (2004) 1.03
Diagnosis of genital herpes by real time PCR in routine clinical practice. Sex Transm Infect (2004) 1.03
Expression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer's disease. Biochem Soc Trans (2005) 1.02
Acetylcholine receptor delta subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita. J Clin Invest (2001) 1.02
The impact of a short course of three lipid lowering drugs on fat oxidation during exercise in healthy volunteers. Postgrad Med J (1993) 1.02
Myasthenia gravis: diagnostic and management dilemmas. Curr Opin Neurol (2001) 1.01
Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. J Clin Invest (1996) 1.01
Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells. Proc Natl Acad Sci U S A (1991) 1.00
Molecular targets for autoimmune and genetic disorders of neuromuscular transmission. Eur J Biochem (2000) 0.99
The impact of single gene and chromosomal disorders on hospital admissions of children and adolescents: a population-based study. Public Health Genomics (2010) 0.98
Effect of 5-Aza-2'-deoxycytidine on the P16 tumor suppressor gene in hepatocellular carcinoma cell line HepG2. World J Gastroenterol (2001) 0.98
Reducing variation in antibacterial prescribing rates for 'cough/cold' and sore throat between 1993 and 2001: regional analyses using the general practice research database. Public Health (2006) 0.97
Pathogenic autoimmunity to affinity-purified mouse acetylcholine receptor induced without adjuvant in BALB/c mice. Eur J Immunol (1993) 0.97
Perceived tutor benefits of teaching near peers: insights from two near peer teaching programmes in South East Scotland. Scott Med J (2013) 0.96
Germline mutation in DOK7 associated with fetal akinesia deformation sequence. J Med Genet (2009) 0.96
Mutation of the acetylcholine receptor epsilon-subunit promoter in congenital myasthenic syndrome. Ann Neurol (1999) 0.95
Synthesis and binding of lactose-specific lectin by isolated lung cells. Am J Physiol (1985) 0.95
Role of isoprenoid lipids on the heterotrimeric G protein gamma subunit in determining effector activation. J Biol Chem (1999) 0.95
Manic syndrome associated with zidovudine treatment. JAMA (1988) 0.94
A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes. J Clin Invest (1998) 0.94
Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidity. J Addict Dis (2000) 0.94
Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030. HIV Clin Trials (2009) 0.93
Effect of antioxidant vitamin supplementation on muscle function after eccentric exercise. Eur J Appl Physiol Occup Physiol (1993) 0.93
Monoclonal antibodies raised against human acetylcholine receptor bind to all five subunits of the fetal isoform. J Neuroimmunol (1999) 0.93
A retrospective cohort study of nasopharyngeal adenocarcinoma: a rare histological type of nasopharyngeal cancer. Clin Otolaryngol (2009) 0.93
Human nicotinic acetylcholine receptor alpha-subunit isoforms: origins and expression. Nucleic Acids Res (1993) 0.92
Functional and non-functional isoforms of the human muscle acetylcholine receptor. J Physiol (1995) 0.92
Two isoforms of the muscle acetylcholine receptor alpha-subunit are translated in the human cell line TE671. FEBS Lett (1991) 0.91
T-cell reactivity in myasthenia gravis. J Autoimmun (1989) 0.91
In vitro proteolytic cleavage of Gazdar murine sarcoma virus p65gag. J Virol (1981) 0.90
The gag-mos hybrid protein of ts110 Moloney murine sarcoma virus: variation of gene expression with temperature. Virology (1984) 0.89
Heterosynaptic long-term depression is facilitated by blockade of inhibition in area CA1 of the hippocampus. Brain Res (1991) 0.89
Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients. Neurology (1991) 0.88
Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis. Immunol Rev (1998) 0.88
Scenarios for autoimmunization of T and B cells in myasthenia gravis. Ann N Y Acad Sci (2003) 0.88
Mapping of autosomal dominant progressive external ophthalmoplegia to a 7-cM critical region on 10q24. Neurology (1999) 0.88
Smoking and mortality in 81,344 drivers in Guangzhou, China. Occup Environ Med (2002) 0.88
Acetylcholine and GABA receptors: subunits of central and peripheral receptors and their encoding nucleic acids. Cold Spring Harb Symp Quant Biol (1983) 0.87
Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell line. J Neuroimmunol (2001) 0.87
IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor. Ann Neurol (2000) 0.87
Association of the APOE epsilon4 allele with disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry (1999) 0.87
Breast-feeding knowledge and attitudes of teenage mothers in Liverpool. J Hum Nutr Diet (2002) 0.87
Characterization of microbial and chemical composition of shuttle wet waste with permanent gas and volatile organic compound analyses. Adv Space Res (2004) 0.87
A comparison of external and self-instructional teaching formats with mentally retarded adults in a vocational training setting. Res Dev Disabil (1987) 0.87
Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss. J Clin Invest (1998) 0.86
Recruiting the occupational and environmental medicine physicians of the future: results of a survey of current residents. J Occup Environ Med (1995) 0.86
Inter-rater reliability and concurrent validity of the Goodenough-Harris and McCarthy Draw-A-Child scoring systems. Percept Mot Skills (1981) 0.86
Study of wrist posture, loading and repetitive motion as risk factors for developing carpal tunnel syndrome. Hand Surg (2007) 0.86
End-plate gamma- and epsilon-subunit mRNA levels in AChR deficiency syndrome due to epsilon-subunit null mutations. Brain (2001) 0.86
Smoking and exposure to occupational hazards in 8,304 workers in Guangzhou, China. Occup Med (Lond) (1996) 0.86
Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1,027 patients. Psychopharmacol Bull (1997) 0.85
The congenital myasthenic syndrome mutation RAPSN N88K derives from an ancient Indo-European founder. J Med Genet (2004) 0.85
Novel functional epsilon-subunit polypeptide generated by a single nucleotide deletion in acetylcholine receptor deficiency congenital myasthenic syndrome. Ann Neurol (1999) 0.85